![](data:image/svg+xml;charset=utf-8,<svg height="32" width="135" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
₹ 1,520.00
Open
1510High
1527.9Low
1502.85Prev Close
1515.15P/E
40.83Median P/E
32.05P/B
6.49Median P/B
4.52Market Cap
3,655.99BPEG
1.61Div.Yield
0.82Bid
-Ask
-Large Cap
3,655.99B Mkt. Cap.Volatility
-Beta
0.72Genie Says
Influencer Count
-| Days | BSE | NSE |
|---|
| 5 | 1,516.15 | 1,516.60 |
| 10 | 1,518.34 | 1,518.56 |
| 20 | 1,558.75 | 1,558.58 |
| 50 | 1,563.15 | 1,563.02 |
| 100 | 1,444.24 | 1,444.20 |
| 300 | 1,292.94 | 1,293.00 |
BSE
524715NSE
SUNPHARMAISIN
INE044A01036Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs). It produces a comprehensive, diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. The Company's vertically integrated network enables it to produce a wide range of pharmaceuticals, including oncology, hormones, peptides, and steroidal drugs. The Company also has a product portfolio in RoW markets, including injectables, hospital products and retail products. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Sezaby and Sprinkle portfolio.
C. S. Muralidharan
Chief Financial OfficerUday Baldota
Chief Executive Officer - Taro Pharmaceutical Industries LimitedS. Damodharan
Chief Executive Officer - API BusinessAbhay Gandhi
Chief Executive Officer - North AmericaKirti Ganorkar
Chief Executive Officer - India BusinessSuresh Rai
Chief Human Resource Officer, Senior Vice PresidentDheeraj Sinha
Executive Vice President, Chief Information OfficerAalok Shanghvi
Whole-time Director, Executive Vice-President, Emerging Markets, Global generic R&D, Global BD (Generics Segment) & APIJila Breeze
Executive Vice President, Global Head - QualityAzadar Khan
Senior Vice-President, Corporate Relations and Corporate Social Responsibility